Rates, variability, and associated factors of polypharmacy in nursing home patients

Yichayaou Beloosesky,1,3 Olga Nenaydenko,2 Revital Feige Gross Nevo,1,3 Abraham Adunsky,2,3 Avraham Weiss1,3 1Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Petah Tikva, 2Department of Geriatric Rehabilitation, Sheba Medical Center, Tel Hashomer, 3Sackler School of Medicine, Tel...

Full description

Bibliographic Details
Main Authors: Beloosesky Y, Nenaydenko O, Gross Nevo RF, Adunsky A, Weiss A
Format: Article
Language:English
Published: Dove Medical Press 2013-11-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/rates-variability-and-associated-factors-of-polypharmacy-in-nursing-ho-peer-reviewed-article-CIA
id doaj-f6bce7a6b77c4cfaa8f61b047bab77c9
record_format Article
spelling doaj-f6bce7a6b77c4cfaa8f61b047bab77c92020-11-24T23:24:40ZengDove Medical PressClinical Interventions in Aging1178-19982013-11-01Volume 81585159015114Rates, variability, and associated factors of polypharmacy in nursing home patientsBeloosesky YNenaydenko OGross Nevo RFAdunsky AWeiss AYichayaou Beloosesky,1,3 Olga Nenaydenko,2 Revital Feige Gross Nevo,1,3 Abraham Adunsky,2,3 Avraham Weiss1,3 1Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Petah Tikva, 2Department of Geriatric Rehabilitation, Sheba Medical Center, Tel Hashomer, 3Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel Objectives: To determine the rate and variability of polypharmacy in nursing home (NH) residents and investigate its relationship to age, sex, functional status, length of stay, and comorbidities. Methods: We conducted a cross sectional, multicenter study that included six nursing homes. Demographic, clinical characteristics, Charlson comorbidity index (CCI), the number and classes of chronic medications, rate of polypharmacy >5 drugs (per day) and polypharmacy >7 drugs (per day) were recorded. Results: Nine hundred and ninety-three residents were included; 750 (75.5%) fully dependent residents and 243 (24.5%) mobile demented residents requiring institutional care. The mean age was 85.04±7.55 (65–108) years. The mean rates of polypharmacy >5 drugs and polypharmacy >7 drugs were 42.6% and 18.6%, respectively. Differences in polypharmacy >5 drugs and polypharmacy >7 drugs were observed in NHs 24.7%–56% and 4.9%–30.4%, respectively (P<0.001). Mean number of chronic drugs per resident was 5.14±2.60 from 3.81±2.24 to 5.95±2.73 (P<0.001). No differences in polypharmacy were found between sex and fully dependent versus mobile demented residents. The most common medications taken were for gastrointestinal, neurological, and cardiovascular disorders. Regression analysis revealed four independent variables for polypharmacy >5 drugs: groups aged 75–84 and >85 relative to 65–74, odds ratio (OR) 0.46 (95% confidence interval [CI] 0.27–0.78) P=0.004, OR 0.35 (95% confidence interval 0.19–0.53), respectively, P<0.001; length of stay >2 years, OR 0.51 (95% CI 0.36–0.73) P<0.001; CCI, OR 1.58 (95% CI 1.42–1.75) P<0.001; and feeding tube versus normal feeding, OR 0.27 (95% CI 0.12–0.60) P=0.001. Conclusion: Rates of polypharmacy in NHs are high with significant variability. Variability rates of polypharmacy, distinct residents' characteristics, and excessive use of certain drug groups may indicate that a decrease in medication is potentially feasible. Keywords: polypharmacy, nursing homes, variability, dementia, dependent, residentshttps://www.dovepress.com/rates-variability-and-associated-factors-of-polypharmacy-in-nursing-ho-peer-reviewed-article-CIAPolypharmacyNursing HomesVariability
collection DOAJ
language English
format Article
sources DOAJ
author Beloosesky Y
Nenaydenko O
Gross Nevo RF
Adunsky A
Weiss A
spellingShingle Beloosesky Y
Nenaydenko O
Gross Nevo RF
Adunsky A
Weiss A
Rates, variability, and associated factors of polypharmacy in nursing home patients
Clinical Interventions in Aging
Polypharmacy
Nursing Homes
Variability
author_facet Beloosesky Y
Nenaydenko O
Gross Nevo RF
Adunsky A
Weiss A
author_sort Beloosesky Y
title Rates, variability, and associated factors of polypharmacy in nursing home patients
title_short Rates, variability, and associated factors of polypharmacy in nursing home patients
title_full Rates, variability, and associated factors of polypharmacy in nursing home patients
title_fullStr Rates, variability, and associated factors of polypharmacy in nursing home patients
title_full_unstemmed Rates, variability, and associated factors of polypharmacy in nursing home patients
title_sort rates, variability, and associated factors of polypharmacy in nursing home patients
publisher Dove Medical Press
series Clinical Interventions in Aging
issn 1178-1998
publishDate 2013-11-01
description Yichayaou Beloosesky,1,3 Olga Nenaydenko,2 Revital Feige Gross Nevo,1,3 Abraham Adunsky,2,3 Avraham Weiss1,3 1Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Petah Tikva, 2Department of Geriatric Rehabilitation, Sheba Medical Center, Tel Hashomer, 3Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel Objectives: To determine the rate and variability of polypharmacy in nursing home (NH) residents and investigate its relationship to age, sex, functional status, length of stay, and comorbidities. Methods: We conducted a cross sectional, multicenter study that included six nursing homes. Demographic, clinical characteristics, Charlson comorbidity index (CCI), the number and classes of chronic medications, rate of polypharmacy >5 drugs (per day) and polypharmacy >7 drugs (per day) were recorded. Results: Nine hundred and ninety-three residents were included; 750 (75.5%) fully dependent residents and 243 (24.5%) mobile demented residents requiring institutional care. The mean age was 85.04±7.55 (65–108) years. The mean rates of polypharmacy >5 drugs and polypharmacy >7 drugs were 42.6% and 18.6%, respectively. Differences in polypharmacy >5 drugs and polypharmacy >7 drugs were observed in NHs 24.7%–56% and 4.9%–30.4%, respectively (P<0.001). Mean number of chronic drugs per resident was 5.14±2.60 from 3.81±2.24 to 5.95±2.73 (P<0.001). No differences in polypharmacy were found between sex and fully dependent versus mobile demented residents. The most common medications taken were for gastrointestinal, neurological, and cardiovascular disorders. Regression analysis revealed four independent variables for polypharmacy >5 drugs: groups aged 75–84 and >85 relative to 65–74, odds ratio (OR) 0.46 (95% confidence interval [CI] 0.27–0.78) P=0.004, OR 0.35 (95% confidence interval 0.19–0.53), respectively, P<0.001; length of stay >2 years, OR 0.51 (95% CI 0.36–0.73) P<0.001; CCI, OR 1.58 (95% CI 1.42–1.75) P<0.001; and feeding tube versus normal feeding, OR 0.27 (95% CI 0.12–0.60) P=0.001. Conclusion: Rates of polypharmacy in NHs are high with significant variability. Variability rates of polypharmacy, distinct residents' characteristics, and excessive use of certain drug groups may indicate that a decrease in medication is potentially feasible. Keywords: polypharmacy, nursing homes, variability, dementia, dependent, residents
topic Polypharmacy
Nursing Homes
Variability
url https://www.dovepress.com/rates-variability-and-associated-factors-of-polypharmacy-in-nursing-ho-peer-reviewed-article-CIA
work_keys_str_mv AT belooseskyy ratesvariabilityandassociatedfactorsofpolypharmacyinnursinghomepatients
AT nenaydenkoo ratesvariabilityandassociatedfactorsofpolypharmacyinnursinghomepatients
AT grossnevorf ratesvariabilityandassociatedfactorsofpolypharmacyinnursinghomepatients
AT adunskya ratesvariabilityandassociatedfactorsofpolypharmacyinnursinghomepatients
AT weissa ratesvariabilityandassociatedfactorsofpolypharmacyinnursinghomepatients
_version_ 1725559518113300480